Patents by Inventor Vincent Delauzun

Vincent Delauzun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
    Patent number: 9822083
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: November 21, 2017
    Assignee: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20170035886
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: October 19, 2016
    Publication date: February 9, 2017
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier
  • AMPHIPHILIC DERIVATIVES OF TRIAZAMACROCYCLIC COMPOUNDS, PRODUCTS AND COMPOSITIONS INCLUDING SAME, AND SYNTHESIS METHODS AND USES THEREOF
    Publication number: 20150353514
    Abstract: The invention relates to amphiphilic derivatives of a triazamacrocyclic compound, as well as to said derivatives as active molecule transporters. The invention also relates to a nanodrug including at least one amphiphilic derivative of a triazamacrocyclic compound and at least one active molecule of a protein such as an antibody, in particular for the treatment of autoimmune diseases or for the treatment of cancer.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 10, 2015
    Applicant: BIOCELLCHALLENGE
    Inventors: Stéphane Moutard, Vincent Delauzun, Laurent Meunier